Search

Search Results
Results 1001 - 1010 of 1077 for Diabetes Type II
  • Vttack
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Piax
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Piax intended for persons living in Australia.
  • Olamlo HCT
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Minax XL
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minax XL (metoprolol succinate) intended for persons living in Australia.
  • Lorstat (New Formulation)
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Lorstat (New Formulation) intended for persons living in Australia.
  • Eleva
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Eleva intended for persons living in Australia.
  • Cilatil
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • Ataris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Ataris (leflunomide) intended for persons living in Australia.
  • Treatment of pressure ulcers (bedsores)
    Health - 27 May 2023
    Pressure ulcers occur in patients who are immobile for a long period or suffer a sustained pressure over an area of skin for a stretch of time. These are difficult to diagnose early and notoriously...
  • Diagnosis of pressure ulcers (bedsores)
    Health - 27 May 2023
    Pressure ulcers or pressure sores are commonly seen among the sick and debilitated individuals admitted to nursing homes with prolonged immobility.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback